Rang	Name	Position
1	Dr. Emil D. Kakkis M.D., Ph.D.	Founder, President, CEO & Director
2	Mr. Howard Horn	Executive VP of Corporate Strategy & CFO
3	Ms. Karah Herdman Parschauer J.D.	Chief Legal Officer & Executive VP of Corporate Affairs
4	Mr. Erik Harris M.B.A.	Executive VP & Chief Commercial Officer
5	Dr. Eric Crombez M.D.	Chief Medical Officer & Executive VP
6	Mr. Theodore A. Huizenga	Senior VP, Corporate Controller & Principal Accounting Officer
7	Mr. Ernie W. Meyer	Chief Human Resources Officer & Executive VP
8	Mr. Vimal Srivastava	Senior Vice President of Business Development & Alliance Management
9	Mr. Dennis Karl Huang	Chief Technical Operations Officer and Executive VP of Gene Therapy Operations
10	Mr. John Richard Pinion II	Chief Quality Operations Officer & Executive VP of Translational Sciences

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	10,81%	0,18 Mrd. USD
2	RTW INVESTMENTS, LLC	7,91%	0,13 Mrd. USD
3	Vanguard Portfolio Management, LLC	6,89%	0,12 Mrd. USD
4	AQR Capital Management LLC	6,65%	0,11 Mrd. USD
5	State Street Corp	6,25%	0,11 Mrd. USD
6	Vanguard Capital Management, LLC	4,36%	0,07 Mrd. USD
7	Two Sigma Investments LLC	3,67%	0,06 Mrd. USD
8	Sands Capital Management, LLC	3,20%	0,05 Mrd. USD
9	Jacobs Levy Equity Management, Inc.	2,98%	0,05 Mrd. USD
10	Frontier Capital Management CO Inc	2,89%	0,05 Mrd. USD
11	Geode Capital Management, LLC	2,62%	0,04 Mrd. USD
12	Bellevue Group AG	2,01%	0,03 Mrd. USD
13	D. E. Shaw & Co LP	1,76%	0,03 Mrd. USD
14	Sofinnova Ventures	1,74%	0,03 Mrd. USD
15	Adage Capital Partners Gp LLC	1,60%	0,03 Mrd. USD
16	GW&K Investment Management, LLC	1,50%	0,03 Mrd. USD
17	MPM Oncology Impact Management LP	1,44%	0,02 Mrd. USD
18	T. Rowe Price Associates, Inc.	1,38%	0,02 Mrd. USD
19	Morgan Stanley - Brokerage Accounts	1,34%	0,02 Mrd. USD
20	Wellington Management Company LLP	1,27%	0,02 Mrd. USD